0001493152-23-006359.txt : 20230301 0001493152-23-006359.hdr.sgml : 20230301 20230301103303 ACCESSION NUMBER: 0001493152-23-006359 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230301 DATE AS OF CHANGE: 20230301 EFFECTIVENESS DATE: 20230301 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ensysce Biosciences, Inc. CENTRAL INDEX KEY: 0001716947 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 822755287 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-474560 FILM NUMBER: 23690618 BUSINESS ADDRESS: STREET 1: 7946 IVANHOE AVENUE STREET 2: SUITE 201 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: (858) 263-4196 MAIL ADDRESS: STREET 1: 7946 IVANHOE AVENUE STREET 2: SUITE 201 CITY: LA JOLLA STATE: CA ZIP: 92037 FORMER COMPANY: FORMER CONFORMED NAME: Leisure Acquisition Corp. DATE OF NAME CHANGE: 20170913 D 1 primary_doc.xml X0708 D LIVE 0001716947 Ensysce Biosciences, Inc. 7946 IVANHOE AVE, SUITE 201 LA JOLLA CA CALIFORNIA 92037 (858) 263-4196 DELAWARE None Leisure Acquisition Corp. Corporation true D Lynn Kirkpatrick 7946 Ivanhoe Ave, Suite 201 La Jolla CA CALIFORNIA 92037 Executive Officer Director Bob Gower 7946 Ivanhoe Ave, Suite 201 La Jolla CA CALIFORNIA 92037 Director William Chang 7946 Ivanhoe Ave, Suite 201 La Jolla CA CALIFORNIA 92037 Director Andrew Benton 7946 Ivanhoe Ave, Suite 201 La Jolla CA CALIFORNIA 92037 Director Steve Martin 7946 Ivanhoe Ave, Suite 201 La Jolla CA CALIFORNIA 92037 Director Adam Levin 7946 Ivanhoe Ave, Suite 201 La Jolla CA CALIFORNIA 92037 Director Curtis Rosebraugh 7946 Ivanhoe Ave, Suite 201 La Jolla CA CALIFORNIA 92037 Director David Humphrey 7946 Ivanhoe Ave, Suite 201 La Jolla CA CALIFORNIA 92037 Executive Officer Lee Rauch 7946 Ivanhoe Ave, Suite 201 La Jolla CA CALIFORNIA 92037 Director Other Health Care Decline to Disclose 06b false 2023-02-02 false true true false 0 H.C. Wainwright & Co., LLC 375 None None 430 PARK AVENUE NEW YORK NY NEW YORK 10022 All States false 2816073 2816073 0 Warrants to purchase common stock to investors for up to 3,571,431 shares at $0.715/share and to designees of H.C. Wainwright & Co., LLC for up to 250,000 shares at $1.05/share in connection with a 2/2/2023 registered direct offering. false 8 210000 0 0 false Ensysce Biosciences, Inc. /s/ Lynn Kirkpatrick Dr. Lynn Kirkpatrick President and CEO 2023-03-01